GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GTBP GT Biopharma Inc.

休市中 03-28 16:00:00 EDT

2.40

+0.10

+4.35%

盘后2.40

+0.000.00%

18:44 EDT

最高2.43	最低2.35	成交量1.57万
今开2.37	昨收2.30	日振幅3.49%
总市值608.74万	流通市值460.56万	总股本253.64万
成交额3.73万	换手率0.82%	流通股本191.90万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GTBP","market":"US","secType":"STK","nameCN":"GT Biopharma Inc.","latestPrice":2.4,"timestamp":1743192000000,"preClose":2.3,"halted":0,"volume":15680,"hourTrading":{"tag":"盘后","latestPrice":2.4,"preClose":2.4,"latestTime":"18:44 EDT","volume":70,"amount":162.48,"timestamp":1743201872592},"delay":0,"floatShares":1919000,"shares":2536397,"eps":-6.936952,"marketStatus":"休市中","change":0.1,"latestTime":"03-28 16:00:00 EDT","open":2.366,"high":2.4302,"low":2.35,"amount":37339.546048,"amplitude":0.03487,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.936952,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1743408000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.3,"postHourTrading":{"tag":"盘后","latestPrice":2.4,"preClose":2.4,"latestTime":"18:44 EDT","volume":70,"amount":162.48,"timestamp":1743201872592},"volumeRatio":0.706892,"impliedVol":3.9697,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/GTBP","defaultTab":"news","newsList":[{"id":"2517317943","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.96%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517317943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517317943?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:49","pubTimestamp":1741186177,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时49分，Gt Biopharma, Inc.股票出现异动，股价急速拉升5.96%。截至发稿，该股报2.31美元/股，成交量3079股，换手率0.14%，振幅2.87%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224937989d49f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224937989d49f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2516670266","title":"Gt Biopharma, Inc.盘中异动 早盘股价大跌6.01%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516670266?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:53","pubTimestamp":1741099990,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时53分，Gt Biopharma, Inc.股票出现波动，股价快速跳水6.01%。截至发稿，该股报2.19美元/股，成交量1.4533万股，换手率0.65%，振幅5.28%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422531096394b51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422531096394b51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2516630584","title":"Gt Biopharma, Inc.盘中异动 早盘快速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516630584?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:07","pubTimestamp":1741014462,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时07分，Gt Biopharma, Inc.股票出现异动，股价急速下挫5.88%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230742a25d4af6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230742a25d4af6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2514385530","title":"Gt Biopharma, Inc.盘中异动 快速跳水6.36%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514385530?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666770,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Gt Biopharma, Inc.股票出现波动，股价快速跳水6.36%。截至发稿，该股报2.21美元/股，成交量8881股，换手率0.40%，振幅2.54%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223250a2567a54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223250a2567a54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2514859064","title":"Gt Biopharma, Inc.盘中异动 快速下挫16.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514859064?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580304,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，Gt Biopharma, Inc.股票出现异动，股价急速下跌16.18%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223144a254f667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223144a254f667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2514741857","title":"Gt Biopharma, Inc.盘中异动 股价大跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514741857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514741857?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:00","pubTimestamp":1740420058,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时00分，Gt Biopharma, Inc.股票出现波动，股价大幅下挫5.58%。截至发稿，该股报2.03美元/股，成交量9705股，换手率0.43%，振幅5.07%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225020058a2524282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225020058a2524282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2512348952","title":"Gt Biopharma, Inc.盘中异动 股价大涨7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512348952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512348952?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:09","pubTimestamp":1739977744,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时09分，Gt Biopharma, Inc.股票出现波动，股价快速拉升7.12%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230905abd508a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230905abd508a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2512109161","title":"Gt Biopharma, Inc.盘中异动 早盘股价大涨5.88%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512109161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512109161?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:30","pubTimestamp":1739892610,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时30分，Gt Biopharma, Inc.股票出现波动，股价快速拉升5.88%。截至发稿，该股报2.27美元/股，成交量8756股，换手率0.39%，振幅2.80%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182330109627a2ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182330109627a2ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2511691069","title":"Gt Biopharma, Inc.盘中异动 早盘快速下挫6.98%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511691069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511691069?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:24","pubTimestamp":1739546689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时24分，Gt Biopharma, Inc.股票出现波动，股价急速下跌6.98%。截至发稿，该股报2.08美元/股，成交量4351股，换手率0.19%，振幅5.80%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423244998859659&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423244998859659&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2511577848","title":"Gt Biopharma, Inc.盘中异动 急速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511577848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511577848?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:01","pubTimestamp":1739480514,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日05时01分，Gt Biopharma, Inc.股票出现异动，股价大幅上涨5.16%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。其相关个股中，Moleculin Biotech, Inc.、Dominari Holdings Inc.、Edesa Biotech, Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3303.31%、2366.89%、1275.50%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021405015496220720&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021405015496220720&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2510336883","title":"Gt Biopharma, Inc.盘中异动 早盘急速上涨7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510336883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510336883?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:37","pubTimestamp":1739288240,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时37分，Gt Biopharma, Inc.股票出现波动，股价大幅拉升7.69%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.84%。其相关个股中，Ocean Biomedical, Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2682.77%、1052.23%、366.02%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、37.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112337209881c977&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112337209881c977&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","GTBP","BK4139"],"gpt_icon":0},{"id":"2510616598","title":"Gt Biopharma, Inc.盘中异动 早盘快速下跌5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510616598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510616598?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:41","pubTimestamp":1739202104,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时41分，Gt Biopharma, Inc.股票出现波动，股价快速下跌5.77%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234144988086e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234144988086e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2509846508","title":"Gt Biopharma, Inc.盘中异动 早盘股价大跌6.67%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509846508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509846508?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:57","pubTimestamp":1738684620,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时57分，Gt Biopharma, Inc.股票出现波动，股价快速下挫6.67%。截至发稿，该股报2.10美元/股，成交量1040股，换手率0.05%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204235700a239399d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204235700a239399d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2508410551","title":"Gt Biopharma, Inc.盘中异动 早盘股价大跌5.38%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508410551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508410551?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:46","pubTimestamp":1738594009,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时46分，Gt Biopharma, Inc.股票出现波动，股价大幅跳水5.38%。截至发稿，该股报2.11美元/股，成交量213股，换手率0.01%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224649987971cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224649987971cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2505886465","title":"Gt Biopharma, Inc.盘中异动 早盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505886465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505886465?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:05","pubTimestamp":1737731102,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时05分，Gt Biopharma, Inc.股票出现异动，股价快速下跌5.11%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230502abb755a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230502abb755a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"gpt_icon":0},{"id":"2505026703","title":"Gt Biopharma, Inc.盘中异动 大幅上涨5.20%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505026703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505026703?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:29","pubTimestamp":1737577782,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时29分，Gt Biopharma, Inc.股票出现异动，股价大幅上涨5.20%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123042942a22bfb44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123042942a22bfb44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2504161622","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.58%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504161622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504161622?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:32","pubTimestamp":1737124323,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时32分，Gt Biopharma, Inc.股票出现异动，股价大幅拉升5.58%。截至发稿，该股报2.46美元/股，成交量2197股，换手率0.10%，振幅5.75%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223203a225bc12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223203a225bc12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2503579615","title":"Gt Biopharma, Inc.盘中异动 股价大跌6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503579615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503579615?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:30","pubTimestamp":1736865027,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时30分，Gt Biopharma, Inc.股票出现波动，股价大幅下跌6.28%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501142230289866022b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501142230289866022b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"gpt_icon":0},{"id":"2501088785","title":"Gt Biopharma, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501088785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501088785?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:18","pubTimestamp":1736263081,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时18分，Gt Biopharma, Inc.股票出现异动，股价急速跳水5.02%。截至发稿，该股报2.84美元/股，成交量4.5434万股，换手率2.03%，振幅7.02%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107231801a218f256&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107231801a218f256&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","IMRX","BK4539","GTBP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.gtbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.04},{"period":"1month","weight":0.0169},{"period":"3month","weight":-0.2053},{"period":"6month","weight":0.1321},{"period":"1year","weight":-0.4582},{"period":"ytd","weight":-0.2131}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GT Biopharma, Inc.于1965年在加利福尼亚州注册成立。该公司是一个临床阶段的生物制药公司，专注于专有的三特异性杀手接合器融合蛋白免疫细胞接合器技术平台的新型免疫肿瘤产品的开发和商业化。TriKE可设计用于针对血液恶性肿瘤或实体肿瘤的任何数量的肿瘤抗原，不需要患者特异性定制。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.028126},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.141386},{"month":3,"riseRate":0.571429,"avgChangeRate":0.052709},{"month":4,"riseRate":0.333333,"avgChangeRate":0.014218},{"month":5,"riseRate":0.571429,"avgChangeRate":0.084634},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.035324},{"month":7,"riseRate":0.285714,"avgChangeRate":0.000588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.081681},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.134536},{"month":10,"riseRate":0.714286,"avgChangeRate":0.052025},{"month":11,"riseRate":0,"avgChangeRate":-0.18843},{"month":12,"riseRate":0.428571,"avgChangeRate":0.043116}],"exchange":"NASDAQ","name":"GT Biopharma Inc.","nameEN":"GT Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GT Biopharma Inc.,GTBP,GT Biopharma Inc.股票,GT Biopharma Inc.股票老虎,GT Biopharma Inc.股票老虎国际,GT Biopharma Inc.行情,GT Biopharma Inc.股票行情,GT Biopharma Inc.股价,GT Biopharma Inc.股市,GT Biopharma Inc.股票价格,GT Biopharma Inc.股票交易,GT Biopharma Inc.股票购买,GT Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}